Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-06 4:17 pm Purchase | 2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 2,207,753 27.000% | 178,298 (+8.79%) | Filing History |
| 2023-06-01 5:00 pm Purchase | 2023-05-25 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 8,418,093 50.800% | 8,418,093 (New Position) | Filing History |
| 2023-05-30 4:15 pm Purchase | 2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 2,029,455 24.800% | 85,000 (+4.37%) | Filing History |
| 2023-05-26 1:14 pm Purchase | 2022-11-04 | 13D | Soleno Therapeutics, Inc. SLNO | SCHULER JACK W | 421,976 4.990% | 421,976 (New Position) | Filing History |
| 2023-05-25 4:58 pm Purchase | 2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,944,455 23.800% | 80,000 (+4.29%) | Filing History |
| 2023-05-18 4:32 pm Purchase | 2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,864,455 22.800% | 1,864,455 (New Position) | Filing History |
| 2023-05-15 5:02 pm Purchase | 2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 8,418,093 19.990% | 8,418,093 (New Position) | Filing History |
| 2023-05-10 4:32 pm Unchanged | 2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-15 07:26 am Sale | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 422,489 5.200% | -30,844 (-6.80%) | Filing History |
| 2023-02-14 5:06 pm Purchase | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 838,534 9.900% | 187,525 (+28.81%) | Filing History |
| 2022-12-20 4:30 pm Sale | 2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | -1,224,571 (Position Closed) | Filing History |
| 2022-08-11 4:56 pm Purchase | 2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,224,571 15.300% | 1,224,571 (New Position) | Filing History |
| 2022-04-08 4:35 pm Purchase | 2022-03-29 | 13D | Soleno Therapeutics, Inc. SLNO | Abingworth LLP | 1,224,558 15.300% | 521,598 (+74.20%) | Filing History |
| 2022-04-05 4:01 pm Sale | 2021-02-18 | 13D | Soleno Therapeutics, Inc. SLNO | Jack W. Schuler Living Trust | 794,120 9.600% | -48,878 (-5.80%) | Filing History |
| 2022-04-05 08:05 am Purchase | 2022-03-29 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 453,333 5.700% | 453,333 (New Position) | Filing History |
| 2022-02-14 08:22 am Unchanged | 2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 651,009 12.200% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:55 pm Sale | 2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -383,880 (Position Closed) | Filing History |
| 2021-07-12 4:01 pm Purchase | 2021-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 651,009 12.200% | 126,252 (+24.06%) | Filing History |
| 2021-02-16 4:02 pm Sale | 2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Larry N. Feinberg | 248,843 4.700% | -131,160 (-34.52%) | Filing History |
| 2021-02-12 3:22 pm Purchase | 2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 524,757 9.900% | 239,562 (+84.00%) | Filing History |